Antagonistic and Immunomodulant Effects of Two Probiotic Strains of Lactobacillus on Clinical Strains of Helicobacter pylori
DOI:
https://doi.org/10.31661/gmj.v9i.1794Keywords:
Gastric Epithelial Cell; Helicobacter pylori; Lactobacillus acidophilus; Lactobacillus rhamnosus; MacrophageAbstract
Background: The present study aimed to evaluate the in vitro and in situ antagonistic effects of Lactobacillus probiotic strains on clinical strains of Helicobacter pylori . Also to investigate their immunomodulation effects on a macrophage cell model. Materials and Methods: Anti-microbial effects of probiotic lactobacilli against H. pylori was assessed using the well and disk diffusion methods. Effects of lactobacilli probiotics strains, as well as their cell-free supernatant on adhesion of H. pylori to MKN-45 gastric epithelial cells, were examined in their presence and absence. Immunomodulation effects of probiotic lactobacilli were performed using the U937 macrophage cell model. Incubation of host cells with probiotics and their cell-free supernatants with cultured host cells was performed in different optimized conditions. The supernatant of host cells cultured in their presence and absence was used for cytokines measurement. Results: Two probioticsâ€, Lactobacillus acidophilus ATCC4356, and Lactobacillus rhamnosus PTCC1607, could inhibit the growth of clinical H. pylori in vitro. They could also inhibit attachment of H. pylori to MKN-45 cells. Cell-free supernatant of L. acidophilus had a stimulating effect on the production of Interferon-gamma (IFN-γ) by U937 cells. Conclusion: The present study demonstrates that, L. acidophilus ATCC4356 and L. rhamnosus PTCC1607 probiotic strains can inhibit the growth of clinical H. pylori in vitro. Treatment of U937 with alive H. pylori plus cell-free supernatant of L. acidophilus, have a significantly higher capacity to stimulate IFN-γ production than H. pylori alone. So, the metabolite (s) of this probiotic may have an immunomodulatory effect in immune response versus H. pylori. [GMJ.2020;9:e1794]
References
Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002; 347:1175-1186. https://doi.org/10.1056/NEJMra020542PMid:12374879 Lopes D, Nunes C, Martins MCL, Sarmento B, Reis S. Eradication of Helicobacter pylori: past, present and future. J Control Release. 2014;189:169-186. https://doi.org/10.1016/j.jconrel.2014.06.020PMid:24969353 Horiki N, Omata F, Uemura M, Suzuki S, Ishii N, Iizuka Y, Fukuda K, Fujita Y, Katsurahara M, Ito T, Cesar GE, Imoto I, Takei Y. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter. 2009;14:86-90. https://doi.org/10.1111/j.1523-5378.2009.00714.xPMid:19751432 Megraud F, Coenen S, Versporten A, Kist M, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y. Study Group participants Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34-42. https://doi.org/10.1136/gutjnl-2012-302254PMid:22580412 Go MF. Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16 Suppl. 1:3-15. https://doi.org/10.1046/j.1365-2036.2002.0160s1003.xPMid:11849122 Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587. https://doi.org/10.1136/bmj.f4587PMid:23926315 PMCid:PMC3736972 Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, Benagiano M, Tasca E, Azzurri , D'Elios MM, Del Prete G, Bernard M. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest. 2006;116:1092-1101. https://doi.org/10.1172/JCI27177PMid:16543949 PMCid:PMC1401483 Emara MH, Mohamed SY, Abdel-Aziz HR. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients:a double-blind placebo-controlled randomized clinical trial. Therap Adv Gastroenterol. 2014;7:4-13. https://doi.org/10.1177/1756283X13503514PMid:24381643 PMCid:PMC3871281 Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des. 2003;9:175-191. https://doi.org/10.2174/1381612033392224PMid:12570667 Vrese MD, Schrezenmei J. Probiotics and non-intestinal infectious conditions. Br J Nutr. 2002;88 Suppl 1:59-66. https://doi.org/10.1079/BJN2002630PMid:12215181 Habermann W, Zimmermann K, Skarabis H, Kunze R, Rusch V. Reduction of acute relapses in patients with chronic recurrent hypertrophic sinusitis during treatment with a bacterial immunostimulant (Enterococus faecalis bacteria of human origin*/a medical probiotic). Arzneimittel Forschung. 2002;52:622_7. https://doi.org/10.1055/s-0031-1299941PMid:12236051 Moal VL, Servin AL. Anti-Infective Activities of Lactobacillus Strains in the Human Intestinal Microbiota: from Probiotics to Gastrointestinal Anti- Infectious Biotherapeutic Agents. Clin. Microbiol. Rev. Clinical Microbiology Reviews. 2014;27(2):167-199. https://doi.org/10.1128/CMR.00080-13PMid:24696432 PMCid:PMC3993101 Yang YJ, Chuang CC, Yang HB, Lu CC, Sheu BS. Lactobacillus acidophilus ameliorates H.pylori induced gastric inflammation by inactivating the Smad7 and NF-B pathways. BMC Microbiology. 2012;12:38. https://doi.org/10.1186/1471-2180-12-38PMid:22429929 PMCid:PMC3340303 Wittig BM, Zeitz M. The gut as an organ of immunology. Int J Colorectal Dis. 2003;18:181-187. https://doi.org/10.1007/s00384-002-0444-1PMid:12673481 Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy. 2003;33:1634-1640. https://doi.org/10.1111/j.1365-2222.2003.01835.xPMid:14656348 Maassen K. Lactobacilli as antigen delivery system for mucosal tolerance in autoimmune disease. PhD thesis. Erasmus University of Rotterdam, the Netherlands. 1999. Miettinen, M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 1998;66:6058-6062. https://doi.org/10.1128/IAI.66.12.6058-6062.1998PMid:9826398 PMCid:PMC108774 Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675-680. https://doi.org/10.1038/90609PMid:11477402 Panpetch W, Thiraworawong T, Tumwasorn S. Human gastric biopsy-derived lactobacilli suppress Helicobacter pylori-induced interleukin-8 production from gastric epithelial cells in vitro. Int J Infereron Cytokine Mediator Res. 2011;3:43-49. https://doi.org/10.2147/IJICMR.S19631 Klerk N, Maudsdotter L, Gebreegziabher H, Saroj SD, Eriksson B, Eriksson OS, Roos S, Linden S, Sjӧlinder H, Jonsson A. Lactobacilli Reduce Helicobacter pylori Attachment to Host Gastric Epithelial Cells by Inhibiting Adhesion Gene Expression. Infect Immun. 2016;84:1526-1535. https://doi.org/10.1128/IAI.00163-16PMid:26930708 PMCid:PMC4862695 Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus irihibits growth of Campylobacter pylori in-vitro. Clin Microbiol Rev. 1989;27:2328-2330. https://doi.org/10.1128/JCM.27.10.2328-2330.1989PMid:2511224 Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion. 1999;60:203-209. https://doi.org/10.1159/000007660PMid:10343133 Oconnor A, Vaira D, Gisbert JP, Morain C. Treatment of Helicobacter pylori infection 2014. Helicobacter. 2014;19 suppl 1:38-45. https://doi.org/10.1111/hel.12163PMid:25167944 Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut. 1997;41:49-55. https://doi.org/10.1136/gut.41.1.49PMid:9274471 PMCid:PMC1027227 Ryan KA, Daly P, Li Y, Hooton C, O'Toole PW. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother. 2008;61:831-834. https://doi.org/10.1093/jac/dkn040PMid:18263567 Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. Lymphocytes in the human gastric mucosa during Helicobacter pylori infection have a T helper cell 1 phenotype. Gastroenterology. 1998;114:482-492. https://doi.org/10.1016/S0016-5085(98)70531-1 Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F, Karttunen R, Crowe SE, Reyes VE, Ernst PB. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun. 1997;65:4229-4235. https://doi.org/10.1128/IAI.65.10.4229-4235.1997PMid:9317031 PMCid:PMC175607 Karttunen R, Karttunen T, Ekre HP, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 1995;36:341-345. https://doi.org/10.1136/gut.36.3.341PMid:7698689 PMCid:PMC1382441 Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, A. Svennerholm M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun. 1998;66:5964-5971. https://doi.org/10.1128/IAI.66.12.5964-5971.1998PMid:9826379 PMCid:PMC108755 Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J, Rollinghoff M, Lohoff M. Antrum- and corpus mucosa-infiltrating CD4_ lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun. 1998;66:5543-5546. https://doi.org/10.1128/IAI.66.11.5543-5546.1998PMid:9784570 PMCid:PMC108696 Gobert AP, Bambou JC, Werts C, Balloy V, Chignard M, Moran AP, Ferrero RL. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a Toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem. 2004;279:245-250. https://doi.org/10.1074/jbc.M307858200PMid:14573621 Harris PR, Ernst PB, Kawabata S, Kiyono H, Graham MF, Smith PD. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J Infect Dis. 1998;178:1516-1520. https://doi.org/10.1086/314426PMid:9780278 Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Investig. 1991;87:894-900. https://doi.org/10.1172/JCI115095PMid:1847939 PMCid:PMC329879 Basu M, Czinn SJ, Blanchard TG. Absence of catalase reduces long-term survival of Helicobacter pylori in macrophage phagosomes. Helicobacter. 2004;9:211-216. https://doi.org/10.1111/j.1083-4389.2004.00226.xPMid:15165256 Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HL, Wilson KT. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA. 2001;98:13844-13849. https://doi.org/10.1073/pnas.241443798PMid:11717441 PMCid:PMC61129 Chaturvedi R, Cheng Y, Asim M, Bussiere FI, Xu H, Gobert AP, Hacker A, Casero RA, Wilson KT. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem. 2004;279:40161-40173. https://doi.org/10.1074/jbc.M401370200PMid:15247269 Cheng Y, Chaturvedi R, Asim M, Bussiere FI, XuH, CaseroRA, Wilson Jr, KT Wilson. Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J Biol Chem. 2005;280:22492-22496. https://doi.org/10.1074/jbc.C500122200PMid:15843384 Gobert AP, Cheng Y, Wang JY, Boucher JL, Iyer RK, Cederbaum SD, Casero RA, Newton JC, and KT Wilson. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol. 2002;168:4692-4700. https://doi.org/10.4049/jimmunol.168.9.4692PMid:11971019 Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I. Lactobacilli and Streptococci Induce Interleukin-12 (IL-12), IL-18, and Gamma Interferon Production in Human Peripheral Blood Mononuclear Cells. Infect Immun. 1998;66:6058-6062. https://doi.org/10.1128/IAI.66.12.6058-6062.1998PMid:9826398 PMCid:PMC108774 Trinchieri G. Interleukin-12 and the regulation of innate resistance and adoptive immunity. Nat. Rev Immunol. 2003;3:133-146. https://doi.org/10.1038/nri1001PMid:12563297 Maassen CB, van Holten-Neelen C, Balk F, den Bak-Glashouwer MJ, Leer RJ, Laman JD, Boersma WJ, Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine. 2000;18:2613-2623. https://doi.org/10.1016/S0264-410X(99)00378-3 Trapp CL, Chang CC, Halpern GM. The influence of chronic yogurt consumption on populations of young and elderly adults. Int J Immunother. 1993;9:53-64. Yang YJ, Sheu BS. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter. 2012;17:297-304. https://doi.org/10.1111/j.1523-5378.2012.00941.xPMid:22759330 Solis Pereyra B, Lemonnier D. Induction of human cytokines by bacteria used in dairy foods. Nutr Res Rev. 1993;13:1127-1140. https://doi.org/10.1016/S0271-5317(05)80737-7 Solis Pereyra B, Aattouri N, Lemonnier D. Role of food in the stimulation of cytokine production. Am J Clin Nutr. 1997;66:521S-525S. https://doi.org/10.1093/ajcn/66.2.421SPMid:9250142 Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun. 1996;64:5403-5405. https://doi.org/10.1128/IAI.64.12.5403-5405.1996PMid:8945595 PMCid:PMC174537 Aiba Y, Suzuki N, Kabir AM, Takagi A, Koda Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murin model. Am J Gastroenterol. 1998;93:2097-2101. https://doi.org/10.1111/j.1572-0241.1998.00600.xPMid:9820379 Coconnier MH, Lievin V, Hemery E, and Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol. 1998;64:4573-4580. https://doi.org/10.1128/AEM.64.11.4573-4580.1998PMid:9797324 PMCid:PMC106686 Michetti P, Dorta G, Brassart D, Vouillamoz D, Schwitzer W, Felley C, Blum AL, Porta N, Rouvet M, Corthesy-Theulaz I. Lactobacillus acidophilus supernatant as an adjuvant in the therapy of H.pylori in humans. Gastroenterology. 1995;108:A166. https://doi.org/10.1016/0016-5085(95)23326-1 Kitazawa H, Matsumura K, Itoh T, Yamaguchi T.: Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus. Microbiol Immunol. 1992;36:311-315. https://doi.org/10.1111/j.1348-0421.1992.tb01668.xPMid:1603000 De Simone C, Vesely R, Bianchi Salvadori B, Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunotherapy. 1993;9:23-28. Pereyra, BS, Lemonnier D. Induction of human cytokines by bacteria used in dairy foods. Nutr Res. 1993;13:1127-1140. https://doi.org/10.1016/S0271-5317(05)80737-7 Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol. 2004;70:518-526. https://doi.org/10.1128/AEM.70.1.518-526.2004PMid:14711683 PMCid:PMC321236 Lin WH, Wu CR, Fang TJ, Guo JT, Huang SY, Lee MS, Yang HL. Anti-Helicobacter pylori activity of fermented milk with lactic acid bacteria. J Sci Food Agric. 2011;91:1424-1431. https://doi.org/10.1002/jsfa.4327PMid:21445876 Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acidmediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol. 1998;93:2097-210. https://doi.org/10.1111/j.1572-0241.1998.00600.xPMid:9820379 Ljungh A, Wadström T. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol. 2006;7:73-89. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh, SK, Valence F, Molle D, Lortal S, Altermann E, Klaenhammer TR, van Kooyk Y. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. PNS USA. 2008;105:19474-19479. https://doi.org/10.1073/pnas.0810305105PMid:19047644 PMCid:PMC2592362 Cotter PD, Ross RP, Hill C. Bacteriocins-aviable alternative to antibiotics? Nat Rev Microbiol. 2013;11:95-105. https://doi.org/10.1038/nrmicro2937PMid:23268227
